Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-06-20

Clinical Trial Update: Konjac-Glucomannan Fibre Blend and American Ginseng in Type 2 Diabetes [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a konjac-glucomannan fibre blend with American ginseng in type 2 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • American Ginseng (Panax quinquefolius)
  • Konjac-Glucomannan Fibre Blend (konjac glucomannan)

Snippet

Sponsor: Vladimir Vuksan | Conditions: Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED